17 September 2014

Prospero House, 241 Borough High Street, London

The meeting will start promptly at 10:00 and is expected to finish at approximately 17:00

Please note that this agenda is subject to change prior to the meeting.

Final Agenda

1.  Welcome and introduction to format of meeting

2.  Apologies

3.  Any other business – Confidential

4.  Minutes from the last Committee meeting held on 19 August 2014

5.  Appraisal of pomalidomide for treating relapsed and refractory multiple myeloma previously treated with both lenalidomide and bortezomib

      5.1.   Declarations of interest - Part 1 only (open session)

      5.2.   Introduction by the Chair, Dr Amanda Adler - Part 1 only (open session)

      5.3.   Presentation by the Lead team, Professor Daniel Hochhauser, Chris O’Regan and Matthew Campbell-Hill - Part 1 and Part 2 (open and closed session)

      5.4.   Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD) - Part 2 only (closed session)

6.  Appraisal of Sipuleucel-T for the first line treatment of metastatic hormone relapsed prostate cancer

      6.1.   Declarations of interest - Part 1 only (open session)

      6.2.   Introduction by the Chair, Dr Amanda Adler - Part 1 only (open session)

      6.3.   Presentation by the Lead team - Part 1 and Part 2 (open and closed session)

      6.4.   Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD) - Part 2 only (closed session)

Print a PDF of the agenda.

Date, time and venue of next meeting 

Next Technology Appraisal (Committee B) Meeting: Tuesday 21 October 2014, 10:00am, ETC venues, Prospero House, 241 Borough High Street, London SE1 1GA

Please note all timings are approximate.

To register

You will receive an automated email response when you submit the registration form. If you do not receive this automated response your registration request has not been received, and you will need to complete and submit the registration form again.

The closing date for registration is Thursday 4 September 2014 at 5pm. Please note that it may not be possible to accept late registration requests.

Should you have queries regarding attending this meeting, please contact the Meetings in Public Coordinator Melinda Kay

Please note that registrants wishing to conduct a research study on the committee meeting and/or NICE processes will require prior permission and should contact NICE Enquiry Handling by email nice@nice.org.uk   Further information about conducting research is also available in our Common Questions and Answers about meetings in public document. 

 

Registration period: 20 August 2014 to 04 September 2014
Registration is closed.